Centric Health Corp. (TSE:CRX – Free Report) – Analysts at Desjardins reduced their FY2024 earnings per share (EPS) estimates for Centric Health in a research report issued to clients and investors on Sunday, November 10th. Desjardins analyst G. Ho now forecasts that the company will post earnings of ($0.03) per share for the year, down from their previous forecast of ($0.02).
A number of other brokerages have also weighed in on CRX. Ventum Cap Mkts upgraded Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th. Stifel Canada lowered Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.
Centric Health Stock Performance
Featured Stories
- Five stocks we like better than Centric Health
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Rocket Lab is the Right Stock for the Right Time
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What Are Dividend Challengers?
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
